Turnkey mRNA therapeutics: what is behind Nutcracker Therapeutics’ technology
…using the multicomponent delivery systems, comprising lipidated peptoid components such as a lipidated cationic peptoid component, and additionally a non-cationic lipididated peptoid component (Multicomponent delivery systems for polyanionic cargo compound delivery – WO2022032058). According to the invention, when the multicomponent delivery systems are complexed with mRNA, they can be used…